发明名称 DAS ÜBERLEBEN DOPAMINERGER NEURONEN FÖRDERNDE FAKTOREN UND DEREN VERWENDUNGEN
摘要 <p>In general, the invention features substantially purified MANF and substantially purified nucleic acids encoding the same. The invention also features a pharmaceutical composition that includes MANF and a pharmaceutically-acceptable excipient, methods for treatment of a neurodegenerative disease, methods for improving dopaminergic neuronal survival during or following cell transplantation, methods for production of neurons for transplantation, and methods for identifying compounds that modulate or mimic MANF's biological activity.</p>
申请公布号 AT485377(T) 申请公布日期 2010.11.15
申请号 AT20020706572T 申请日期 2002.03.20
申请人 CNS PROTEIN THERAPEUTICS, INC. 发明人 COMMISSIONG, JOHN;RAIBEKAS, ANDREI
分类号 C12N15/09;C12N15/12;A61K35/30;A61K38/00;A61K38/17;A61K38/22;A61P25/00;A61P43/00;C07K14/47;C07K14/475;C12N5/07;C12N5/08;C12N15/861;C12N15/867 主分类号 C12N15/09
代理机构 代理人
主权项
地址